Closure of Trading Window
Sub: Closure of Trading Window for the un-audited financial results for the quarter ended 30.06.2017 Ref: Our Company's letter dated 22.08.2017 Please note that due to postponement of the Board meeting the trading window in respect of the Company's Securities shall remain closed for all the Directors/Officers/Designed Employees of the Company from the trading hours on 22.08.2017 till close of the trading hours on 04.09.2017... Board Meeting Postponed
Sub: postponement of Board meeting for considering the un audited results Ref: Our Company's letter dated 22.08.2017 With reference to the subject cited, this is to inform the Exchange that the meeting of the Board of Directors of M/s. Concord Drugs Limited which was scheduled to be held on Monday, 28.08.2017 at 10:00 a.m. at the registered office of the company at Survey No.249, Brahmanapally Village, Hayatnagar Mandal - 501511,... Statements Of Investor Complaints For 30.06.2017
With reference to the subject cited, please find attached the Statement of Grievance Redressal Mechanism under Regulation 13(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 for the quarter ended 30.06.2017: Particulars Three Months ended 30/06/2017 INVESTOR COMPLAINTS Pending at the beginning of the quarter NIL Received during the quarter NIL Disposed of during the quarter NIL Remaining unresolved at the end of the quarter NIL Shareholding for the Period Ended June 30, 2017
Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here Audited Financial Results For The Quarter And Year Ended 31.03.2017
Audited financial results for the quarter and year ended 31.03.2017 Closure of Trading Window
The trading window in respect of the Company's Securities shall remain closed for all the Directors/Officers/Designed Employees of the Company from the trading hours on 17.05.2017 till close of the trading hours on 01.06.2017 as per the code of Internal Procedure and Conduct for Prevention of Insider Trading adopted by the Company for declaration of audited financial results for the quarter and year ended 31.03.2017. Board Meeting On 30.05.2017
Board meeting on 30.05.2017 for consideration of audited financial results for the quarter and year ended 31.03.2017. Compliance Certificate For The Half Year Ended 31.03.2017
Compliance certificate for the half year ended 31.03.2017 Shareholding for the Period Ended March 31, 2017
Concord Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here